Carroll Financial Associates’s Incyte INCY Stock Holding History

Carroll Financial Associates’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10	Closed	–	–	1841
2021 Q2	$0	Buy	+10	New	+$834	﹤0.01%	1761

Other funds holding INCY

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Carroll Financial Associates's INCY Position: Q3 2021 in Review

Carroll Financial Associates sold out of Incyte (INCY) in Q3 2021, closing a stake of 10 shares.

Carroll Financial Associates first reported a position in INCY in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 494 funds tracked by Wall St. Rank hold INCY as of Q3 2021.

Carroll Financial Associates reported no remaining Incyte position as of Q3 2021 after selling out during the quarter.
Carroll Financial Associates sold 10 Incyte shares in Q3 2021.
Carroll Financial Associates first reported a position in Incyte in Q2 2021 and held it in 1 quarter.
Carroll Financial Associates's Incyte position peaked at $0 in Q2 2021.
494 funds tracked by Wall St. Rank held Incyte as of Q3 2021.

Based on Carroll Financial Associates's 13F filing for Q3 2021, filed 7 Oct 2021.